A 54-week, randomized, open-label, multicenter study to assess the long-term safety and tolerability of the combination of aliskiren 300 mg/ amlodipine 10 mg in patients with essential hypertension

Update Il y a 4 ans
Reference: EUCTR2006-003629-98

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the long-term (6 month and 12 month) safety of the combinations of aliskiren 300mg/ amlodipine 10 mg in patients with essential hypertension


Inclusion criteria

  • Hypertension